GLP-1 receptor agonists, while useful clinical tools, are not sufficient alone to address the obesity epidemic; addressing the broader metabolic and social factors is necessary alongside pharmacotherapy.
normativepending
Speaker
Unidentified Speaker — GLP-1 Aren’t Just Weight Loss Drugs: A Provocative Discovery [5nGTUaqKmcY]Evidence Quote
“that doesn't mean it does not mean that gp1s aren't a useful tool that they don't have their place but they're not enough let's not lose sight of the metabolic forest for one very financially fruitful tree”
Created: 8/11/2026, 7:45:10 AM
Your notes
Loading notes...